DCM
Discovery Capital Management’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-4,001,856
| Closed | -$283K | – | 69 |
|
2023
Q4 | $283K | Sell |
4,001,856
-11,459,973
| -74% | -$810K | 0.04% | 48 |
|
2023
Q3 | $2.04M | Sell |
15,461,829
-181,194
| -1% | -$23.9K | 0.36% | 33 |
|
2023
Q2 | $7.98M | Hold |
15,643,023
| – | – | 0.84% | 31 |
|
2023
Q1 | $9.86M | Sell |
15,643,023
-542,975
| -3% | -$342K | 1.12% | 20 |
|
2022
Q4 | $10.5M | Buy |
16,185,998
+1,543,039
| +11% | +$1M | 1.53% | 20 |
|
2022
Q3 | $25.2M | Buy |
14,642,959
+517,880
| +4% | +$891K | 3.76% | 5 |
|
2022
Q2 | $17.5M | Buy |
14,125,079
+111,986
| +0.8% | +$139K | 2.26% | 14 |
|
2022
Q1 | $9.14M | Buy |
14,013,093
+666,600
| +5% | +$435K | 0.78% | 25 |
|
2021
Q4 | $14.5M | Buy |
13,346,493
+800,000
| +6% | +$872K | 1.09% | 22 |
|
2021
Q3 | $22.8M | Buy |
12,546,493
+59,266
| +0.5% | +$108K | 1.71% | 11 |
|
2021
Q2 | $33M | Buy |
12,487,227
+437,220
| +4% | +$1.15M | 2.13% | 8 |
|
2021
Q1 | $43.4M | Buy |
12,050,007
+57,984
| +0.5% | +$209K | 5.81% | 6 |
|
2020
Q4 | $30.2M | Buy |
11,992,023
+1,585,173
| +15% | +$3.99M | 3.73% | 8 |
|
2020
Q3 | $26.2M | Buy |
10,406,850
+764,090
| +8% | +$1.93M | 4.02% | 7 |
|
2020
Q2 | $31.6M | Buy |
9,642,760
+100,000
| +1% | +$328K | 5.74% | 5 |
|
2020
Q1 | $23.4M | Buy |
9,542,760
+4,846,014
| +103% | +$11.9M | 6.43% | 5 |
|
2019
Q4 | $22.2M | Buy |
4,696,746
+505,619
| +12% | +$2.39M | 7.04% | 4 |
|
2019
Q3 | $17.9M | Buy |
4,191,127
+1,439,739
| +52% | +$6.16M | 3% | 12 |
|
2019
Q2 | $16M | Buy |
2,751,388
+994,575
| +57% | +$5.8M | 1.53% | 19 |
|
2019
Q1 | $6.76M | Buy |
+1,756,813
| New | +$6.76M | 0.7% | 22 |
|